RPS25P10: A Promising Drug Target / Biomarker (G100271372)

Target Name: RPS25P10

NCBI ID: G100271372

RPS25P10

Other Name(s): Ribosomal protein S25 pseudogene 10 | ribosomal protein S25 pseudogene 10 | RPS25_3_1755

RPS25P10: A Promising Drug Target / Biomarker

The protein RPS25P10 is a member of the Rho family of GTPases, which are a group of proteins that play a crucial role in cell signaling and transport. RPS25P10 is a 25kDa protein that is expressed in various cell types, including neurons, muscle cells, and red blood cells. It is highly conserved, with a sequence identity of 94% between its human and mouse counterparts. One of the unique features of RPS25P10 is its ability to interact with various protein partners, including the protein Parkin, which is a key regulator of the Rho GTPase signaling pathway.

The Rho family of GTPases is involved in a wide range of cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport. RPS25P10 is involved in these processes as well, playing a role in the regulation of cell signaling and the maintenance of cytoskeletal organization.

Drug Targeting

RPS25P10 is a drug target of interest because of its involvement in the regulation of cell signaling. Many diseases are caused by the disruption of normal cellular signaling pathways. The Rho family of GTPases plays a critical role in the regulation of these signaling pathways, and RPS25P10 is a key regulator of the Rho GTPase signaling pathway.

The Rho GTPase signaling pathway is a complex process that involves the interaction of various protein partners, including RPS25P10. This pathway is involved in the regulation of various cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport.

One of the unique features of RPS25P10 is its ability to interact with various protein partners, including the protein Parkin. Parkin is a key regulator of the Rho GTPase signaling pathway, and it plays a role in the regulation of cellular processes such as cell signaling, cytoskeletal organization, and vesicle transport.

The disruption of the Rho GTPase signaling pathway has been linked to the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, the targeting of RPS25P10 as a drug target is of great interest.

Biomarker

RPS25P10 is also a potential biomarker for certain diseases. The Rho family of GTPases is involved in the regulation of various cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport. Therefore, the expression of RPS25P10 may be a potential biomarker for certain diseases.

For example, the expression of RPS25P10 has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, the expression of RPS25P10 may be a potential biomarker for these diseases.

Conclusion

In conclusion, RPS25P10 is a protein that is involved in the regulation of various cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport. It is a key regulator of the Rho GTPase signaling pathway and is a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of RPS25P10 in these processes and to develop effective treatments for the disorders associated with its dysfunction.

Protein Name: Ribosomal Protein S25 Pseudogene 10

The "RPS25P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS25P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets